| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.815 | 0.002 | 0.815 | Alpha-N-acetylglucosaminidase inhibitor | 0.508 0.005 DBMET00503 | ||
| 0.745 | 0.002 | 0.745 | Expectorant | 0.686 0.002 DBMET00503 | ||
| 0.741 | 0.002 | 0.893 | Peroxidase inhibitor | 0.893 0.001 DBMET00503 | DBMET00503 | |
| 0.739 | 0.001 | 0.739 | Mucolytic | 0.664 0.002 DBMET00503 | ||
| 0.737 | 0.004 | 0.738 | Interleukin antagonist | 0.738 0.004 DBMET00503 | DBMET00503 | |
| 0.731 | 0.002 | 0.783 | Glutamate dehydrogenase inhibitor | 0.783 0.001 DBMET00503 | DBMET00503 | |
| 0.702 | 0.002 | 0.97 | Glutamate decarboxylase inhibitor | 0.97 0.001 DBMET00503 | DBMET00503 | |
| 0.647 | 0.003 | 0.647 | Leukotriene A4 hydrolase inhibitor | 0.611 0.003 DBMET00503 | ||
| 0.641 | 0.002 | 0.842 | Phenylalanine 4-hydroxylase inhibitor | 0.842 0.001 DBMET00503 | DBMET00503 | |
| 0.642 | 0.014 | 0.805 | Aldehyde oxidase inhibitor | 0.805 0.004 DBMET00503 | DBMET00503 | |
| 0.616 | 0.006 | 0.723 | Superoxide dismutase inhibitor | 0.723 0.004 DBMET00503 | DBMET00503 | |
| 0.602 | 0.004 | 0.764 | Phospholipase C inhibitor | 0.764 0.002 DBMET00503 | DBMET00503 | |
| 0.572 | 0.002 | 0.845 | Histidine decarboxylase inhibitor | 0.845 0.001 DBMET00503 | DBMET00503 | |
| 0.543 | 0.004 | 0.599 | Chelator | 0.599 0.004 DBMET00503 | DBMET00503 | |
| 0.556 | 0.022 | 0.556 | Immunostimulant | 0.524 0.026 DBMET00503 | ||
| 0.509 | 0.002 | 0.547 | Catalase inhibitor | 0.547 0.001 DBMET00503 | DBMET00503 | |
| 0.515 | 0.018 | 0.515 | Apoptosis antagonist | 0.348 0.056 DBMET00503 | ||
| 0.471 | 0.002 | 0.488 | Angiotensin-converting enzyme inhibitor | 0.488 0.002 DBMET00503 | DBMET00503 | |
| 0.471 | 0.003 | 0.817 | Ornithine carbamoyltransferase inhibitor | 0.817 0.001 DBMET00503 | DBMET00503 | |
| 0.481 | 0.013 | 0.488 | Angiogenesis stimulant | 0.488 0.012 DBMET00503 | DBMET00503 | |
| 0.442 | 0.004 | 0.692 | Aminopeptidase B inhibitor | 0.692 0.002 DBMET00503 | DBMET00503 | |
| 0.451 | 0.015 | 0.451 | Insulysin inhibitor | 0.447 0.015 DBMET00503 | ||
| 0.433 | 0.009 | 0.517 | Thrombolytic | 0.517 0.005 DBMET00503 | DBMET00503 | |
| 0.409 | 0.004 | 0.546 | Succinate dehydrogenase inhibitor | 0.546 0.003 DBMET00503 | DBMET00503 | |
| 0.418 | 0.019 | 0.44 | DNA synthesis inhibitor | 0.44 0.018 DBMET00503 | DBMET00503 | |
| 0.399 | 0.003 | 0.612 | NMDA receptor agonist | 0.612 0.002 DBMET00503 | DBMET00503 | |
| 0.429 | 0.036 | 0.532 | Immunomodulator | 0.532 0.019 DBMET00503 | DBMET00503 | |
| 0.412 | 0.033 | 0.493 | Antioxidant | 0.493 0.021 DBMET00503 | DBMET00503 | |
| 0.402 | 0.027 | 0.423 | Interleukin 2 agonist | 0.423 0.021 DBMET00503 | DBMET00503 | |
| 0.401 | 0.029 | 0.489 | Free radical scavenger | 0.489 0.017 DBMET00503 | DBMET00503 | |
| 0.37 | 0.002 | 0.442 | Neutral endopeptidase inhibitor | 0.442 0.002 DBMET00503 | DBMET00503 | |
| 0.416 | 0.06 | 0.421 | Transcription factor NF kappa B inhibitor | 0.421 0.059 DBMET00503 | DBMET00503 | |
| 0.358 | 0.002 | 0.418 | Aminopeptidase I inhibitor | 0.418 0.002 DBMET00503 | DBMET00503 | |
| 0.353 | 0.003 | 0.386 | Endothelin-converting enzyme inhibitor | 0.386 0.003 DBMET00503 | DBMET00503 | |
| 0.355 | 0.011 | 0.355 | Peptidyltransferase inhibitor | 0.274 0.036 DBMET00503 | ||
| 0.366 | 0.025 | 0.366 | Interleukin agonist | 0.291 0.053 DBMET00503 | ||
| 0.4 | 0.061 | 0.4 | Calpain 2 inhibitor | 0.212 0.177 DBMET00503 | ||
| 0.341 | 0.004 | 0.598 | Alcohol dehydrogenase inhibitor | 0.598 0.002 DBMET00503 | DBMET00503 | |
| 0.326 | 0.005 | 0.436 | Adenylate kinase inhibitor | 0.436 0.002 DBMET00503 | DBMET00503 | |
| 0.337 | 0.019 | 0.337 | Calpain inhibitor | 0.276 0.044 DBMET00503 | ||
| 0.391 | 0.081 | 0.391 | Antibacterial | 0.35 0.102 DBMET00503 | ||
| 0.318 | 0.01 | 0.447 | Aldehyde dehydrogenase inhibitor | 0.447 0.005 DBMET00503 | DBMET00503 | |
| 0.306 | 0.006 | 0.354 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.354 0.004 DBMET00503 | DBMET00503 | |
| 0.321 | 0.024 | 0.45 | Tyrosine 3 hydroxylase inhibitor | 0.45 0.005 DBMET00503 | DBMET00503 | |
| 0.316 | 0.02 | 0.441 | Diuretic | 0.441 0.011 DBMET00503 | DBMET00503 | |
| 0.298 | 0.003 | 0.459 | Farnesyltransferase inhibitor | 0.459 0.003 DBMET00503 | DBMET00503 | |
| 0.314 | 0.026 | 0.444 | Hepatoprotectant | 0.444 0.01 DBMET00503 | DBMET00503 | |
| 0.289 | 0.003 | 0.289 | Glutathione S-transferase inhibitor | 0.256 0.004 DBMET00503 | ||
| 0.373 | 0.089 | 0.373 | Histamine release inhibitor | 0.334 0.107 DBMET00503 | ||
| 0.291 | 0.019 | 0.548 | Amylase inhibitor | 0.548 0.005 DBMET00503 | DBMET00503 | |
| 0.283 | 0.021 | 0.306 | Lipid peroxidase inhibitor | 0.306 0.018 DBMET00503 | DBMET00503 | |
| 0.27 | 0.018 | 0.27 | Neurotensin receptor agonist | 0.256 0.02 DBMET00503 | ||
| 0.264 | 0.013 | 0.264 | Cell adhesion inhibitor | 0.227 0.018 DBMET00503 | ||
| 0.273 | 0.038 | 0.335 | Growth hormone agonist | 0.335 0.026 DBMET00503 | DBMET00503 | |
| 0.256 | 0.024 | 0.256 | Bone formation stimulant | 0.237 0.028 DBMET00503 | ||
| 0.232 | 0.006 | 0.237 | Integrin antagonist | 0.237 0.005 DBMET00503 | DBMET00503 | |
| 0.286 | 0.06 | 0.286 | Transcription factor STAT3 inhibitor | |||
| 0.226 | 0.005 | 0.226 | Toll-Like receptor 2 agonist | 0.198 0.007 DBMET00503 | ||
| 0.23 | 0.013 | 0.23 | Toll-Like receptor 2 antagonist | 0.187 0.03 DBMET00503 | ||
| 0.24 | 0.041 | 0.303 | Anticoagulant | 0.303 0.028 DBMET00503 | DBMET00503 | |
| 0.2 | 0.004 | 0.293 | Aminopeptidase microsomal inhibitor | 0.293 0.003 DBMET00503 | DBMET00503 | |
| 0.204 | 0.009 | 0.204 | Caspase 3 inhibitor | 0.116 0.066 DBMET00503 | ||
| 0.199 | 0.004 | 0.305 | Integrin alpha5beta1 antagonist | 0.305 0.004 DBMET00503 | DBMET00503 | |
| 0.217 | 0.022 | 0.377 | Mannose-6-phosphate isomerase inhibitor | 0.377 0.003 DBMET00503 | DBMET00503 | |
| 0.26 | 0.068 | 0.32 | Platelet antagonist | 0.32 0.047 DBMET00503 | DBMET00503 | |
| 0.204 | 0.012 | 0.375 | Porphobilinogen synthase inhibitor | 0.375 0.004 DBMET00503 | DBMET00503 | |
| 0.198 | 0.009 | 0.198 | Metalloproteinase-9 inhibitor | 0.154 0.014 DBMET00503 | ||
| 0.234 | 0.045 | 0.235 | Insulin sensitizer | 0.235 0.044 DBMET00503 | DBMET00503 | |
| 0.206 | 0.017 | 0.206 | Cyclooxygenase 3 inhibitor | 0.146 0.052 DBMET00503 | ||
| 0.221 | 0.033 | 0.221 | Phospholipase A2 inhibitor | 0.208 0.038 DBMET00503 | ||
| 0.213 | 0.026 | 0.213 | Histone deacetylase SIRT1 inhibitor | 0.157 0.056 DBMET00503 | ||
| 0.188 | 0.001 | 0.188 | Membrane dipeptidase inhibitor | 0.181 0.001 DBMET00503 | ||
| 0.19 | 0.007 | 0.19 | Ribonucleoside-diphosphate reductase inhibitor | 0.163 0.01 DBMET00503 | ||
| 0.185 | 0.003 | 0.185 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.183 0.003 DBMET00503 | ||
| 0.189 | 0.009 | 0.189 | Matrix metalloproteinase inhibitor | 0.146 0.014 DBMET00503 | ||
| 0.191 | 0.012 | 0.36 | Phosphofructokinase-1 inhibitor | 0.36 0.004 DBMET00503 | DBMET00503 | |
| 0.278 | 0.1 | 0.278 | Sodium/bile acid cotransporter inhibitor | 0.214 0.169 DBMET00503 | ||
| 0.187 | 0.008 | 0.187 | Ribonucleotide reductase inhibitor | 0.159 0.011 DBMET00503 | ||
| 0.232 | 0.055 | 0.316 | DNA methyltransferase I inhibitor | 0.316 0.021 DBMET00503 | DBMET00503 | |
| 0.18 | 0.004 | 0.273 | Aminopeptidase N inhibitor | 0.273 0.003 DBMET00503 | DBMET00503 | |
| 0.197 | 0.023 | 0.28 | Ferrochelatase inhibitor | 0.28 0.009 DBMET00503 | DBMET00503 | |
| 0.194 | 0.021 | 0.5 | GABA C receptor agonist | 0.5 0.004 DBMET00503 | DBMET00503 | |
| 0.18 | 0.009 | 0.18 | Neutrophil collagenase inhibitor | 0.143 0.013 DBMET00503 | ||
| 0.272 | 0.109 | 0.307 | Antithrombotic | 0.307 0.084 DBMET00503 | DBMET00503 | |
| 0.195 | 0.034 | 0.342 | Monophenol monooxygenase inhibitor | 0.342 0.014 DBMET00503 | DBMET00503 | |
| 0.169 | 0.009 | 0.437 | Carbamoyl phosphate synthetase inhibitor | 0.437 0.003 DBMET00503 | DBMET00503 | |
| 0.246 | 0.09 | 0.246 | Transcription factor STAT inhibitor | |||
| 0.191 | 0.036 | 0.193 | M17 leucyl aminopeptidase inhibitor | 0.193 0.035 DBMET00503 | DBMET00503 | |
| 0.154 | 0.003 | 0.154 | Angiotensin-converting enzyme 2 inhibitor | 0.14 0.003 DBMET00503 | ||
| 0.218 | 0.068 | 0.32 | DNA methylase inhibitor | 0.32 0.023 DBMET00503 | DBMET00503 | |
| 0.152 | 0.004 | 0.327 | Mannosidase inhibitor | 0.327 0.002 DBMET00503 | DBMET00503 | |
| 0.169 | 0.022 | 0.19 | Carbonic anhydrase III inhibitor | 0.19 0.018 DBMET00503 | DBMET00503 | |
| 0.173 | 0.027 | 0.173 | Beta amyloid protein antagonist | 0.16 0.034 DBMET00503 | ||
| 0.262 | 0.117 | 0.351 | Cholesterol antagonist | 0.351 0.064 DBMET00503 | DBMET00503 | |
| 0.158 | 0.014 | 0.173 | Hematopoietic | 0.173 0.012 DBMET00503 | DBMET00503 | |
| 0.153 | 0.01 | 0.192 | GP IIb/IIIa receptor antagonist | 0.192 0.007 DBMET00503 | DBMET00503 | |
| 0.146 | 0.004 | 0.324 | Alpha-mannosidase inhibitor | 0.324 0.002 DBMET00503 | DBMET00503 | |
| 0.145 | 0.005 | 0.152 | Botulinum neurotoxin type A inhibitor | 0.152 0.004 DBMET00503 | DBMET00503 | |
| 0.224 | 0.084 | 0.224 | Antiamyloidogenic | 0.159 0.135 DBMET00503 | ||
| 0.142 | 0.003 | 0.243 | Geranylgeranyltransferase I inhibitor | 0.243 0.002 DBMET00503 | DBMET00503 | |
| 0.262 | 0.123 | 0.281 | Vasodilator, coronary | 0.281 0.104 DBMET00503 | DBMET00503 | |
| 0.155 | 0.018 | 0.369 | Aminoacyl-tRNA synthetase inhibitor | 0.369 0.004 DBMET00503 | DBMET00503 | |
| 0.136 | 0.003 | 0.331 | Lysine carboxypeptidase inhibitor | 0.331 0.001 DBMET00503 | DBMET00503 | |
| 0.148 | 0.017 | 0.191 | Chymotrypsin inhibitor | 0.191 0.01 DBMET00503 | DBMET00503 | |
| 0.164 | 0.036 | 0.203 | Antibacterial (Helicobacter pylori) | 0.203 0.021 DBMET00503 | DBMET00503 | |
| 0.23 | 0.103 | 0.394 | 5 Hydroxytryptamine uptake stimulant | 0.394 0.015 DBMET00503 | DBMET00503 | |
| 0.146 | 0.019 | 0.146 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.141 | 0.016 | 0.188 | Somatostatin 1 agonist | 0.188 0.008 DBMET00503 | DBMET00503 | |
| 0.156 | 0.03 | 0.181 | Interleukin 8 antagonist | 0.181 0.019 DBMET00503 | DBMET00503 | |
| 0.144 | 0.02 | 0.144 | Metalloproteinase-2 inhibitor | 0.1 0.038 DBMET00503 | ||
| 0.132 | 0.01 | 0.132 | Sirtuin 1 inhibitor | 0.116 0.016 DBMET00503 | ||
| 0.137 | 0.016 | 0.163 | Factor XII inhibitor | 0.163 0.01 DBMET00503 | DBMET00503 | |
| 0.126 | 0.005 | 0.205 | Growth hormone release inhibitor | 0.205 0.004 DBMET00503 | DBMET00503 | |
| 0.159 | 0.039 | 0.208 | Adenylate cyclase inhibitor | 0.208 0.024 DBMET00503 | DBMET00503 | |
| 0.159 | 0.04 | 0.159 | Cathepsin H inhibitor | 0.142 0.052 DBMET00503 | ||
| 0.13 | 0.011 | 0.13 | Human rhinovirus A protease inhibitor | 0.057 0.037 DBMET00503 | ||
| 0.124 | 0.005 | 0.124 | Phospholipase D inhibitor | 0.123 0.005 DBMET00503 | ||
| 0.177 | 0.058 | 0.177 | Protein-tyrosine phosphatase inhibitor | |||
| 0.141 | 0.023 | 0.155 | Anabolic | 0.155 0.015 DBMET00503 | DBMET00503 | |
| 0.213 | 0.098 | 0.213 | Neuropeptide Y2 antagonist | 0.188 0.143 DBMET00503 | ||
| 0.116 | 0.002 | 0.236 | Aminopeptidase A inhibitor | 0.236 0.001 DBMET00503 | DBMET00503 | |
| 0.123 | 0.009 | 0.123 | Matrix metalloproteinase 1 inhibitor | 0.095 0.015 DBMET00503 | ||
| 0.119 | 0.005 | 0.119 | Integrin alpha4 antagonist | 0.099 0.006 DBMET00503 | ||
| 0.194 | 0.081 | 0.194 | Amyloid beta aggregation inhibitor | |||
| 0.114 | 0.003 | 0.247 | Arginase inhibitor | 0.247 0.001 DBMET00503 | DBMET00503 | |
| 0.24 | 0.13 | 0.24 | Thyroid hormone antagonist | |||
| 0.12 | 0.011 | 0.12 | Matrix metalloproteinase (membrane-type) inhibitor | 0.091 0.016 DBMET00503 | ||
| 0.153 | 0.045 | 0.153 | Proteasome inhibitor | |||
| 0.162 | 0.054 | 0.223 | Cell wall synthesis inhibitor | 0.223 0.022 DBMET00503 | DBMET00503 | |
| 0.138 | 0.03 | 0.169 | Urease inhibitor | 0.169 0.015 DBMET00503 | DBMET00503 | |
| 0.141 | 0.034 | 0.141 | Protease inhibitor | |||
| 0.121 | 0.015 | 0.276 | Argininosuccinate synthase inhibitor | 0.276 0.004 DBMET00503 | DBMET00503 | |
| 0.164 | 0.058 | 0.164 | Thiol protease inhibitor | 0.128 0.101 DBMET00503 | ||
| 0.145 | 0.039 | 0.145 | Falcipain 3 inhibitor | |||
| 0.159 | 0.054 | 0.28 | Alkaline phosphatase inhibitor | 0.28 0.015 DBMET00503 | DBMET00503 | |
| 0.112 | 0.008 | 0.112 | Metalloproteinase-3 inhibitor | 0.092 0.012 DBMET00503 | ||
| 0.19 | 0.087 | 0.439 | Pyruvate kinase inhibitor | 0.439 0.015 DBMET00503 | DBMET00503 | |
| 0.107 | 0.004 | 0.107 | HCV NS3/NS4A protease inhibitor | 0.079 0.011 DBMET00503 | ||
| 0.133 | 0.03 | 0.159 | Folate antagonist | 0.159 0.019 DBMET00503 | DBMET00503 | |
| 0.116 | 0.013 | 0.152 | Acyl-CoA dehydrogenase inhibitor | 0.152 0.009 DBMET00503 | DBMET00503 | |
| 0.105 | 0.003 | 0.11 | Carboxypeptidase B inhibitor | 0.11 0.003 DBMET00503 | DBMET00503 | |
| 0.103 | 0.005 | 0.111 | VLA-4 antagonist | 0.111 0.005 DBMET00503 | DBMET00503 | |
| 0.119 | 0.022 | 0.119 | Selectin antagonist | 0.118 0.023 DBMET00503 | ||
| 0.217 | 0.123 | 0.236 | Gastrin inhibitor | 0.236 0.097 DBMET00503 | DBMET00503 | |
| 0.098 | 0.005 | 0.126 | Vanilloid 2 antagonist | 0.126 0.004 DBMET00503 | DBMET00503 | |
| 0.152 | 0.06 | 0.183 | Adenylate cyclase stimulant | 0.183 0.024 DBMET00503 | DBMET00503 | |
| 0.094 | 0.006 | 0.094 | Collagenase inhibitor | 0.069 0.01 DBMET00503 | ||
| 0.088 | 0.004 | 0.088 | Peptide deformylase inhibitor | 0.057 0.008 DBMET00503 | ||
| 0.12 | 0.039 | 0.12 | Factor V inhibitor | 0.12 0.039 DBMET00503 | ||
| 0.096 | 0.017 | 0.096 | Neuraminidase inhibitor | |||
| 0.098 | 0.019 | 0.098 | Cathepsin D inhibitor | 0.052 0.04 DBMET00503 | ||
| 0.096 | 0.019 | 0.096 | NMDA receptor glycine site agonist | 0.095 0.019 DBMET00503 | ||
| 0.084 | 0.006 | 0.084 | Thymidylate synthase inhibitor | 0.075 0.009 DBMET00503 | ||
| 0.085 | 0.009 | 0.085 | DNA helicase inhibitor | 0.077 0.012 DBMET00503 | ||
| 0.084 | 0.01 | 0.084 | Carbonic anhydrase IV inhibitor | 0.072 0.013 DBMET00503 | ||
| 0.103 | 0.03 | 0.156 | Analgesic, opioid | 0.156 0.014 DBMET00503 | DBMET00503 | |
| 0.118 | 0.046 | 0.137 | Toll-Like receptor 4 antagonist | 0.137 0.029 DBMET00503 | DBMET00503 | |
| 0.11 | 0.039 | 0.169 | Triose-phosphate isomerase inhibitor | 0.169 0.015 DBMET00503 | DBMET00503 | |
| 0.076 | 0.008 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.072 0.009 DBMET00503 | ||
| 0.084 | 0.016 | 0.147 | Phosphorylase inhibitor | 0.147 0.007 DBMET00503 | DBMET00503 | |
| 0.089 | 0.021 | 0.168 | Alcohol oxidase inhibitor | 0.168 0.009 DBMET00503 | DBMET00503 | |
| 0.086 | 0.019 | 0.176 | Glutamate (mGluR6) antagonist | 0.176 0.003 DBMET00503 | DBMET00503 | |
| 0.172 | 0.105 | 0.219 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.219 0.059 DBMET00503 | DBMET00503 | |
| 0.086 | 0.021 | 0.086 | Collagenase 3 inhibitor | 0.065 0.036 DBMET00503 | ||
| 0.068 | 0.004 | 0.095 | Geranylgeranyltransferase inhibitor | 0.095 0.003 DBMET00503 | DBMET00503 | |
| 0.112 | 0.049 | 0.114 | UDP-glucose 4-epimerase inhibitor | 0.114 0.048 DBMET00503 | DBMET00503 | |
| 0.075 | 0.012 | 0.075 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.024 DBMET00503 | ||
| 0.064 | 0.003 | 0.1 | Aminopeptidase P inhibitor | 0.1 0.002 DBMET00503 | DBMET00503 | |
| 0.107 | 0.047 | 0.111 | Glutamate (mGluR7) agonist | 0.111 0.041 DBMET00503 | DBMET00503 | |
| 0.073 | 0.012 | 0.106 | Adenosine deaminase inhibitor | 0.106 0.005 DBMET00503 | DBMET00503 | |
| 0.089 | 0.029 | 0.103 | Glucagon-like peptide 1 agonist | 0.103 0.02 DBMET00503 | DBMET00503 | |
| 0.067 | 0.008 | 0.067 | Caspase 2 inhibitor | 0.027 0.026 DBMET00503 | ||
| 0.107 | 0.049 | 0.128 | Electrolyte absorption antagonist | 0.128 0.031 DBMET00503 | DBMET00503 | |
| 0.066 | 0.009 | 0.066 | Neuraminidase (Influenza A) inhibitor | |||
| 0.265 | 0.208 | 0.355 | 5 Hydroxytryptamine release inhibitor | 0.355 0.111 DBMET00503 | DBMET00503 | |
| 0.107 | 0.052 | 0.172 | Creatine kinase inhibitor | 0.172 0.016 DBMET00503 | DBMET00503 | |
| 0.184 | 0.129 | 0.195 | Hypoglycemic | 0.195 0.117 DBMET00503 | DBMET00503 | |
| 0.116 | 0.062 | 0.116 | Photosensitizer | 0.113 0.067 DBMET00503 | ||
| 0.071 | 0.017 | 0.083 | Complement C3a chemotactic receptor antagonist | 0.083 0.013 DBMET00503 | DBMET00503 | |
| 0.068 | 0.015 | 0.068 | Macrophage elastase inhibitor | 0.068 0.015 DBMET00503 | ||
| 0.117 | 0.065 | 0.117 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.121 | 0.069 | 0.121 | Histone deacetylase class III inhibitor | |||
| 0.11 | 0.059 | 0.191 | DOPA decarboxylase inhibitor | 0.191 0.008 DBMET00503 | DBMET00503 | |
| 0.059 | 0.007 | 0.129 | Glutamate (mGluR8) agonist | 0.129 0.002 DBMET00503 | DBMET00503 | |
| 0.077 | 0.026 | 0.077 | Caspase 9 inhibitor | |||
| 0.075 | 0.027 | 0.075 | Carbonic anhydrase I inhibitor | 0.062 0.034 DBMET00503 | ||
| 0.071 | 0.025 | 0.119 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.119 0.011 DBMET00503 | DBMET00503 | |
| 0.053 | 0.007 | 0.074 | Bradykinin B2 receptor agonist | 0.074 0.004 DBMET00503 | DBMET00503 | |
| 0.062 | 0.017 | 0.062 | Erythropoietin receptor agonist | 0.039 0.029 DBMET00503 | ||
| 0.077 | 0.033 | 0.077 | Neuropeptide agonist | |||
| 0.046 | 0.003 | 0.053 | Carboxypeptidase B2 inhibitor | 0.053 0.002 DBMET00503 | DBMET00503 | |
| 0.053 | 0.011 | 0.108 | Kainate receptor agonist | 0.108 0.003 DBMET00503 | DBMET00503 | |
| 0.073 | 0.031 | 0.073 | Neuraminidase (influenza) inhibitor | |||
| 0.072 | 0.03 | 0.089 | Carbonic anhydrase stimulant | 0.089 0.022 DBMET00503 | DBMET00503 | |
| 0.059 | 0.018 | 0.062 | Oxytocin agonist | 0.062 0.015 DBMET00503 | DBMET00503 | |
| 0.06 | 0.019 | 0.06 | Nicotinic receptor alpha3 subunit antagonist | 0.053 0.023 DBMET00503 | ||
| 0.057 | 0.016 | 0.057 | Histone deacetylase 7 inhibitor | |||
| 0.097 | 0.057 | 0.097 | Falcipain inhibitor | |||
| 0.072 | 0.034 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.045 | 0.006 | 0.045 | LFA antagonist | 0.04 0.008 DBMET00503 | ||
| 0.142 | 0.104 | 0.146 | Dual specificity phosphatase inhibitor | 0.146 0.098 DBMET00503 | DBMET00503 | |
| 0.051 | 0.013 | 0.051 | Histone deacetylase 11 inhibitor | 0.045 0.015 DBMET00503 | ||
| 0.051 | 0.013 | 0.051 | Histone deacetylase class IV inhibitor | 0.045 0.015 DBMET00503 | ||
| 0.047 | 0.01 | 0.047 | Integrin alpha1beta1 antagonist | 0.046 0.011 DBMET00503 | ||
| 0.068 | 0.031 | 0.068 | Cathepsin L inhibitor | 0.064 0.034 DBMET00503 | ||
| 0.086 | 0.05 | 0.104 | Carbonic anhydrase VI inhibitor | 0.104 0.037 DBMET00503 | DBMET00503 | |
| 0.069 | 0.033 | 0.129 | Biliverdin reductase inhibitor | 0.129 0.012 DBMET00503 | DBMET00503 | |
| 0.054 | 0.019 | 0.054 | AICAR transformylase inhibitor | 0.051 0.021 DBMET00503 | ||
| 0.048 | 0.014 | 0.126 | Fumarate hydratase inhibitor | 0.126 0.004 DBMET00503 | DBMET00503 | |
| 0.193 | 0.16 | 0.193 | Thyroid hormone beta antagonist | |||
| 0.046 | 0.013 | 0.047 | VCAM-1 antagonist | 0.047 0.011 DBMET00503 | DBMET00503 | |
| 0.046 | 0.013 | 0.047 | VCAM antagonist | 0.047 0.011 DBMET00503 | DBMET00503 | |
| 0.039 | 0.006 | 0.052 | Integrin alpha4beta7 antagonist | 0.052 0.005 DBMET00503 | DBMET00503 | |
| 0.04 | 0.008 | 0.07 | Vitronectin receptor antagonist | 0.07 0.005 DBMET00503 | DBMET00503 | |
| 0.089 | 0.058 | 0.138 | NADH dehydrogenase inhibitor | 0.138 0.021 DBMET00503 | DBMET00503 | |
| 0.081 | 0.05 | 0.089 | Interferon agonist | 0.089 0.04 DBMET00503 | DBMET00503 | |
| 0.058 | 0.027 | 0.093 | Antimetabolite | 0.093 0.017 DBMET00503 | DBMET00503 | |
| 0.035 | 0.005 | 0.035 | ICAM 1 antagonist | 0.031 0.006 DBMET00503 | ||
| 0.052 | 0.022 | 0.052 | Leukocyte elastase inhibitor | 0.043 0.029 DBMET00503 | ||
| 0.067 | 0.037 | 0.067 | Nitric oxide donor | |||
| 0.107 | 0.08 | 0.176 | Alkylator | 0.176 0.034 DBMET00503 | DBMET00503 | |
| 0.034 | 0.008 | 0.034 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.014 DBMET00503 | ||
| 0.079 | 0.054 | 0.079 | Cell adhesion molecule inhibitor | 0.073 0.063 DBMET00503 | ||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase II inhibitor | 0.052 0.042 DBMET00503 | ||
| 0.037 | 0.013 | 0.061 | Glutamate (mGluR3) agonist | 0.061 0.004 DBMET00503 | DBMET00503 | |
| 0.087 | 0.062 | 0.087 | Falcipain 2 inhibitor | |||
| 0.132 | 0.108 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.148 0.047 DBMET00503 | DBMET00503 | |
| 0.066 | 0.042 | 0.066 | Carbonic anhydrase inhibitor | 0.056 0.05 DBMET00503 | ||
| 0.1 | 0.078 | 0.171 | GABA C receptor antagonist | 0.171 0.021 DBMET00503 | DBMET00503 | |
| 0.073 | 0.05 | 0.15 | Glycine receptor agonist | 0.15 0.007 DBMET00503 | DBMET00503 | |
| 0.051 | 0.029 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 DBMET00503 | DBMET00503 | |
| 0.037 | 0.017 | 0.037 | Histone deacetylase 10 inhibitor | 0.033 0.019 DBMET00503 | ||
| 0.042 | 0.021 | 0.042 | Factor XIIIa inhibitor | 0.036 0.027 DBMET00503 | ||
| 0.027 | 0.006 | 0.027 | Caspase 8 inhibitor | |||
| 0.055 | 0.035 | 0.055 | Protein 50S ribosomal subunit inhibitor | |||
| 0.143 | 0.123 | 0.166 | Psychostimulant | 0.166 0.103 DBMET00503 | DBMET00503 | |
| 0.029 | 0.009 | 0.17 | Glutamate (mGluR1a) agonist | 0.17 0.003 DBMET00503 | DBMET00503 | |
| 0.037 | 0.019 | 0.037 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.027 DBMET00503 | ||
| 0.024 | 0.006 | 0.025 | Carbonic anhydrase X inhibitor | 0.025 0.005 DBMET00503 | DBMET00503 | |
| 0.024 | 0.006 | 0.025 | Carbonic anhydrase VIII inhibitor | 0.025 0.005 DBMET00503 | DBMET00503 | |
| 0.081 | 0.065 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.097 | 0.081 | 0.13 | Nav1.4 sodium channel blocker | 0.13 0.044 DBMET00503 | DBMET00503 | |
| 0.046 | 0.03 | 0.052 | Neurotensin receptor antagonist | 0.052 0.027 DBMET00503 | DBMET00503 | |
| 0.037 | 0.021 | 0.037 | Calcitonin receptor agonist | 0.036 0.022 DBMET00503 | ||
| 0.089 | 0.073 | 0.111 | Xanthine oxidase inhibitor | 0.111 0.052 DBMET00503 | DBMET00503 | |
| 0.05 | 0.035 | 0.05 | CD45 antagonist | |||
| 0.055 | 0.04 | 0.055 | Cathepsin B inhibitor | |||
| 0.024 | 0.009 | 0.024 | Neuraminidase (Influenza B) inhibitor | |||
| 0.037 | 0.022 | 0.073 | Glutamate (mGluR8) antagonist | 0.073 0.004 DBMET00503 | DBMET00503 | |
| 0.03 | 0.015 | 0.03 | Histone deacetylase class IIb inhibitor | 0.025 0.019 DBMET00503 | ||
| 0.052 | 0.038 | 0.052 | Elastase inhibitor | |||
| 0.128 | 0.115 | 0.135 | Interferon gamma antagonist | 0.135 0.101 DBMET00503 | DBMET00503 | |
| 0.029 | 0.016 | 0.029 | Histone deacetylase 6 inhibitor | 0.024 0.019 DBMET00503 | ||
| 0.026 | 0.014 | 0.131 | Glutamate (mGluR1) agonist | 0.131 0.003 DBMET00503 | DBMET00503 | |
| 0.034 | 0.022 | 0.041 | Prostacyclin antagonist | 0.041 0.017 DBMET00503 | DBMET00503 | |
| 0.039 | 0.028 | 0.072 | AMPA 4 receptor antagonist | 0.072 0.007 DBMET00503 | DBMET00503 | |
| 0.017 | 0.005 | 0.017 | Integrin beta2 antagonist | |||
| 0.038 | 0.026 | 0.038 | Cholecystokinin B agonist | 0.034 0.032 DBMET00503 | ||
| 0.023 | 0.012 | 0.035 | Integrin beta7 antagonist | 0.035 0.008 DBMET00503 | DBMET00503 | |
| 0.069 | 0.059 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.088 0.044 DBMET00503 | DBMET00503 | |
| 0.034 | 0.023 | 0.034 | HCV polyprotein inhibitor | |||
| 0.019 | 0.01 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET00503 | DBMET00503 | |
| 0.041 | 0.032 | 0.041 | DNA gyrase subunit A inhibitor | |||
| 0.05 | 0.04 | 0.053 | Carbonic anhydrase II stimulant | 0.053 0.033 DBMET00503 | DBMET00503 | |
| 0.019 | 0.01 | 0.019 | Ileal bile acid transport inhibitor | |||
| 0.038 | 0.029 | 0.038 | Histone deacetylase 9 inhibitor | |||
| 0.028 | 0.02 | 0.028 | Histone deacetylase class II inhibitor | |||
| 0.036 | 0.028 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 DBMET00503 | DBMET00503 | |
| 0.022 | 0.013 | 0.022 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.038 | 0.03 | 0.038 | Aggrecanase 1 inhibitor | 0.037 0.033 DBMET00503 | ||
| 0.032 | 0.024 | 0.032 | Histone deacetylase 5 inhibitor | |||
| 0.018 | 0.01 | 0.018 | Integrin alpha4beta1 antagonist | |||
| 0.06 | 0.053 | 0.063 | Interferon inducer | 0.063 0.046 DBMET00503 | DBMET00503 | |
| 0.014 | 0.007 | 0.114 | Glutamate (mGluR6) agonist | 0.114 0.001 DBMET00503 | DBMET00503 | |
| 0.06 | 0.053 | 0.06 | Histone deacetylase inhibitor | |||
| 0.071 | 0.065 | 0.096 | GABA B receptor agonist | 0.096 0.019 DBMET00503 | DBMET00503 | |
| 0.082 | 0.076 | 0.149 | HIV-1 integrase (Overall Integration) inhibitor | 0.149 0.026 DBMET00503 | DBMET00503 | |
| 0.055 | 0.049 | 0.055 | Cathepsin E inhibitor | |||
| 0.014 | 0.008 | 0.014 | Integrin alphaLbeta2 antagonist | |||
| 0.129 | 0.124 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.104 DBMET00503 | DBMET00503 | |
| 0.119 | 0.115 | 0.154 | Hemostatic | 0.154 0.063 DBMET00503 | DBMET00503 | |
| 0.041 | 0.037 | 0.042 | Dihydroorotase inhibitor | 0.042 0.034 DBMET00503 | DBMET00503 | |
| 0.029 | 0.025 | 0.029 | Histone deacetylase 4 inhibitor | |||
| 0.031 | 0.028 | 0.031 | Calpain 1 inhibitor | |||
| 0.118 | 0.115 | 0.182 | Insulin secretagoues | 0.182 0.047 DBMET00503 | DBMET00503 | |
| 0.021 | 0.019 | 0.021 | Histone deacetylase 3 inhibitor | |||
| 0.029 | 0.026 | 0.029 | Caspase 6 inhibitor | |||
| 0.027 | 0.026 | 0.027 | Histone deacetylase class IIa inhibitor | |||
| 0.032 | 0.033 | 0.13 | Glutamate (mGluR3) antagonist | 0.13 0.004 DBMET00503 | DBMET00503 | |
| 0.165 | 0.166 | 0.208 | Nitric-oxide synthase stimulant | 0.208 0.076 DBMET00503 | DBMET00503 | |
| 0.016 | 0.018 | 0.03 | Tryptophan hydroxylase 1 inhibitor | 0.03 0.004 DBMET00503 | DBMET00503 | |
| 0.045 | 0.048 | 0.103 | Aconitate hydratase inhibitor | 0.103 0.008 DBMET00503 | DBMET00503 | |
| 0.121 | 0.125 | 0.159 | Arachidonic acid antagonist | 0.159 0.077 DBMET00503 | DBMET00503 | |
| 0.11 | 0.114 | 0.12 | Vanilloid 1 agonist | 0.12 0.089 DBMET00503 | DBMET00503 | |
| 0.017 | 0.023 | 0.021 | Growth hormone releasing factor antagonist | 0.021 0.018 DBMET00503 | DBMET00503 | |
| 0.061 | 0.068 | 0.065 | Cathepsin G inhibitor | 0.065 0.06 DBMET00503 | DBMET00503 | |
| 0.02 | 0.027 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.014 DBMET00503 | DBMET00503 | |
| 0.042 | 0.051 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.039 DBMET00503 | DBMET00503 | |
| 0.017 | 0.027 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.017 DBMET00503 | DBMET00503 | |
| 0.056 | 0.067 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET00503 | DBMET00503 | |
| 0.034 | 0.046 | 0.165 | Glutamate (mGluR group III) agonist | 0.165 0.004 DBMET00503 | DBMET00503 | |
| 0.103 | 0.115 | 0.152 | Protein kinase stimulant | 0.152 0.067 DBMET00503 | DBMET00503 | |
| 0.011 | 0.024 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 DBMET00503 | DBMET00503 | |
| 0.018 | 0.032 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET00503 | DBMET00503 | |
| 0.061 | 0.075 | 0.064 | MDM2 inhibitor | 0.064 0.059 DBMET00503 | DBMET00503 | |
| 0.03 | 0.046 | 0.054 | Tryptophan 5 hydroxylase inhibitor | 0.054 0.004 DBMET00503 | DBMET00503 | |
| 0.039 | 0.057 | 0.054 | Carbonic anhydrase VB inhibitor | 0.054 0.041 DBMET00503 | DBMET00503 | |
| 0.012 | 0.032 | 0.021 | Telomerase stimulant | 0.021 0.007 DBMET00503 | DBMET00503 | |
| 0.08 | 0.1 | 0.126 | GABA C receptor rho-1 antagonist | 0.126 0.035 DBMET00503 | DBMET00503 | |
| 0.047 | 0.069 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.029 DBMET00503 | DBMET00503 | |
| 0.074 | 0.096 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 DBMET00503 | DBMET00503 | |
| 0.063 | 0.087 | 0.129 | Ornithine decarboxylase inhibitor | 0.129 0.02 DBMET00503 | DBMET00503 | |
| 0.062 | 0.086 | 0.09 | Keratolytic | 0.09 0.038 DBMET00503 | DBMET00503 | |
| 0.079 | 0.107 | 0.215 | Cystathionine beta-synthase inhibitor | 0.215 0.021 DBMET00503 | DBMET00503 | |
| 0.07 | 0.099 | 0.124 | Prolactin inhibitor | 0.124 0.035 DBMET00503 | DBMET00503 | |
| 0.026 | 0.055 | 0.037 | Dihydropteroate synthase inhibitor | 0.037 0.03 DBMET00503 | DBMET00503 | |
| 0.022 | 0.053 | 0.045 | Somatostatin 1 antagonist | 0.045 0.023 DBMET00503 | DBMET00503 | |
| 0.033 | 0.065 | 0.083 | Glutamate (mGluR4) antagonist | 0.083 0.008 DBMET00503 | DBMET00503 | |
| 0.056 | 0.094 | 0.116 | GABA aminotransferase inhibitor | 0.116 0.018 DBMET00503 | DBMET00503 | |
| 0.013 | 0.055 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 DBMET00503 | DBMET00503 | |
| 0.006 | 0.049 | 0.033 | Kainate receptor 1 antagonist | 0.033 0.009 DBMET00503 | DBMET00503 | |
| 0.028 | 0.073 | 0.038 | Thymidine kinase inhibitor | 0.038 0.033 DBMET00503 | DBMET00503 | |
| 0.043 | 0.087 | 0.061 | Purinergic P2X1 antagonist | 0.061 0.041 DBMET00503 | DBMET00503 | |
| 0.035 | 0.081 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.058 0.018 DBMET00503 | DBMET00503 | |
| 0.038 | 0.084 | 0.08 | NMDA 2C receptor antagonist | 0.08 0.025 DBMET00503 | DBMET00503 | |
| 0.016 | 0.062 | 0.059 | Kainate receptor 2 antagonist | 0.059 0.012 DBMET00503 | DBMET00503 | |
| 0.181 | 0.234 | 0.234 | GABA C receptor rho-3 antagonist | 0.234 0.169 DBMET00503 | DBMET00503 | |
| 0.016 | 0.07 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET00503 | DBMET00503 | |
| 0.022 | 0.079 | 0.07 | Glutamate (mGluR4) agonist | 0.07 0.007 DBMET00503 | DBMET00503 | |
| 0.108 | 0.165 | 0.135 | Melanin inhibitor | 0.135 0.105 DBMET00503 | DBMET00503 | |
| 0.046 | 0.104 | 0.075 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.056 DBMET00503 | DBMET00503 | |
| 0.018 | 0.076 | 0.047 | AMPA receptor agonist | 0.047 0.011 DBMET00503 | DBMET00503 | |
| 0.078 | 0.136 | 0.111 | Microtubule formation inhibitor | 0.111 0.072 DBMET00503 | DBMET00503 | |
| 0.072 | 0.133 | 0.104 | M18 aspartyl aminopeptidase inhibitor | 0.104 0.087 DBMET00503 | DBMET00503 | |
| 0.029 | 0.09 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.049 0.016 DBMET00503 | DBMET00503 | |
| 0.057 | 0.119 | 0.204 | Inducible nitric-oxide synthase inhibitor | 0.204 0.008 DBMET00503 | DBMET00503 | |
| 0.016 | 0.079 | 0.059 | Kainate receptor antagonist | 0.059 0.017 DBMET00503 | DBMET00503 | |
| 0.008 | 0.07 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.014 DBMET00503 | DBMET00503 | |
| 0.099 | 0.163 | 0.146 | Dual specificity phosphatase 3 inhibitor | 0.146 0.1 DBMET00503 | DBMET00503 | |
| 0.008 | 0.074 | 0.027 | Somatostatin 5 antagonist | 0.027 0.025 DBMET00503 | DBMET00503 | |
| 0.145 | 0.212 | 0.207 | RNA-directed DNA polymerase inhibitor | 0.207 0.09 DBMET00503 | DBMET00503 | |
| 0.01 | 0.078 | 0.033 | AMPA 2 receptor antagonist | 0.033 0.018 DBMET00503 | DBMET00503 | |
| 0.045 | 0.12 | 0.098 | Glutamate (mGluR7) antagonist | 0.098 0.012 DBMET00503 | DBMET00503 | |
| 0.029 | 0.107 | 0.069 | Glutamate (mGluR group III) antagonist | 0.069 0.01 DBMET00503 | DBMET00503 | |
| 0.013 | 0.092 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.021 DBMET00503 | DBMET00503 | |
| 0.019 | 0.105 | 0.044 | Guanylate cyclase inhibitor | 0.044 0.028 DBMET00503 | DBMET00503 | |
| 0.02 | 0.12 | 0.044 | NMDA receptor subunit 3B antagonist | 0.044 0.03 DBMET00503 | DBMET00503 | |
| 0.059 | 0.163 | 0.179 | Nitric-oxide synthase inhibitor | 0.179 0.014 DBMET00503 | DBMET00503 | |
| 0.016 | 0.121 | 0.044 | NMDA 2A receptor antagonist | 0.044 0.043 DBMET00503 | DBMET00503 | |
| 0.013 | 0.128 | 0.064 | NMDA receptor subunit 3A antagonist | 0.064 0.016 DBMET00503 | DBMET00503 | |
| 0.088 | 0.204 | 0.143 | Anesthetic general | 0.143 0.122 DBMET00503 | DBMET00503 | |
| 0.055 | 0.182 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 DBMET00503 | DBMET00503 | |
| 0.095 | 0.223 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.066 DBMET00503 | DBMET00503 | |
| 0.009 | 0.147 | 0.292 | Kinesin antagonist | 0.292 0.003 DBMET00503 | DBMET00503 | |
| 0.009 | 0.147 | 0.292 | Kinesin-like protein 1 inhibitor | 0.292 0.003 DBMET00503 | DBMET00503 | |
| 0.026 | 0.165 | 0.077 | Sphingosine 1-phosphate receptor 4 agonist | 0.077 0.039 DBMET00503 | DBMET00503 | |
| 0.083 | 0.223 | 0.123 | Sphingosine 1-phosphate receptor 2 antagonist | 0.123 0.09 DBMET00503 | DBMET00503 | |
| 0.048 | 0.194 | 0.098 | Phosphodiesterase I inhibitor | 0.098 0.046 DBMET00503 | DBMET00503 | |
| 0.116 | 0.265 | 0.262 | 5 Hydroxytryptamine release stimulant | 0.262 0.084 DBMET00503 | DBMET00503 | |
| 0.059 | 0.222 | 0.087 | Glutamate release inhibitor | 0.087 0.07 DBMET00503 | DBMET00503 | |
| 0.027 | 0.221 | 0.074 | NMDA receptor antagonist | 0.074 0.073 DBMET00503 | DBMET00503 | |
| 0.03 | 0.229 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.056 DBMET00503 | DBMET00503 | |
| 0.018 | 0.232 | 0.133 | Glutamate receptor agonist | 0.133 0.022 DBMET00503 | DBMET00503 | |
| 0.028 | 0.265 | 0.084 | Histamine N-methyltransferase inhibitor | 0.084 0.062 DBMET00503 | DBMET00503 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |